Sino Amer Pharmaceutical Profession
Nonprofit profile at a glance
- EIN
- 934136992
- IRS 990-EZ coverage
- 2023–2024
- Forms available
- Form 990-EZ 2024
- Location
- Jamaica Plain, MA, USA
- Phone
- 6178660174
- Rating
- 72
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Professional Societies, Associations
Reported finances
- Revenue
- $148,630
- Expenses
- $87,770
- Assets
- $346,250
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- HUIJUAN LI (President)
- YUEMEI ZHANG (President)
People named in this filing
- HUIJUAN LI (President)
- YUEMEI ZHANG (President)
- Haishan Li (Treasurer)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Promote pharmaceutical industry
What it reported doing in 2024
SAPA-NE 26th Annual ConferencePioneer New Era of Pharmaceutical Industry with Innovation of Emerging Modality. 349 guests was served.
Operating model
- Revenue model
- Earned-program. 81% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - The filed numbers largely add up and program spending has grown recently. A relatively small share of available resources goes toward mission work.
Rating breakdown
- Financial Efficiency: 59
- Transparency & Controls: 82
- Sustainability: 86
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 47.3%; rating input score 47
- Program expense ratio: 80.1%; rating input score 80
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 40.9%; rating input score 90; 90th percentile among comparable filings
- Total-asset coverage ratio: 3.94; rating input score 94; 94th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 76; 76th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: 21.5% per year; rating input score 100; 78th percentile among comparable filings
- Revenue growth: 23.5% per year; rating input score 100; 86th percentile among comparable filings
- Asset growth: 19.3% per year; rating input score 100; 79th percentile among comparable filings
Details
- Where the money goes: 47.3% of revenue deployed · 80.1% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 3 filed program accomplishments · $70K in reported program spending
- Leadership: top reported pay $0 · 4 people listed
- Consistency: 7 of 7 current checks pass
- Schedules: 2 filed schedules
- Filing history: 2 filing years from 2023 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Financial Efficiency: Mission deployment rate scored 47/100.